| Regulatory Challenges |
| April 18, 2013 - May 20, 2013 |
|
|
| INTERPHEX 2013 |
| April 1, 2013 - April 15, 2013 |
|
|
| Biosimilars |
| February 21, 2013 - April 1, 2013 |
|
|
| US Biotechnology Hubs |
| January 24, 2013 - February 21, 2013 |
|
|
| Regulatory Enforcement |
| December 11, 2012 - January 21, 2013 |
|
|
| Trade Shows |
| November 13, 2012 - December 11, 2012 |
|
|
| Patent Cliff |
| October 30, 2012 - November 13, 2012 |
|
|
| FDA confidentiality |
| October 16, 2012 - October 30, 2012 |
|
|
| Preventing counterfeiting |
| October 2, 2012 - October 16, 2012 |
|
|
| European Pharmacovigilance Activities |
| September 18, 2012 - October 2, 2012 |
|
|
| Generic Drug User Fees Amendments of 2012 |
| September 4, 2012 - September 18, 2012 |
|
|
| European Legislation |
| August 21, 2012 - September 4, 2012 |
|
|
| Drug Settlements |
| August 7, 2012 - August 21, 2012 |
|
|
| Emerging Markets |
| July 24, 2012 - August 7, 2012 |
|
|
| Energy Efficiency |
| July 10, 2012 - July 24, 2012 |
|
|
| Energy Efficiency |
| June 25, 2012 - July 24, 2012 |
|
|
| Affordable Care Act |
| June 25, 2012 - July 9, 2012 |
|
|
| Drug Shortages |
| June 11, 2012 - June 25, 2012 |
|
|
| Transparency |
| May 21, 2012 - June 11, 2012 |
|
|
| Significant changes |
| May 7, 2012 - May 21, 2012 |
|
|
| Quality Management |
| April 25, 2012 - May 7, 2012 |
|
|
| Analytical equipment |
| April 10, 2012 - April 26, 2012 |
|
|
| DTC Advertising |
| March 27, 2012 - April 11, 2012 |
|
|
| Biologics Manufacturing |
| March 12, 2012 - March 26, 2012 |
|
|
| Powder properties |
| February 27, 2012 - March 12, 2012 |
|
|
| Sterile manufacturing |
| February 13, 2012 - February 27, 2012 |
|
|
| Social media |
| January 30, 2012 - February 13, 2012 |
|
|
| API Manufacturing |
| January 16, 2012 - January 30, 2012 |
|
|
| Lyophilization Advances |
| January 2, 2012 - January 16, 2012 |
|
|
| Injection technologies |
| December 19, 2011 - January 2, 2012 |
|
|
| Oral drug delivery |
| December 5, 2011 - December 18, 2011 |
|
|
| Generic-Drug User Fees |
| November 21, 2011 - December 5, 2011 |
|
|
| Innovation in Solid Dosage |
| November 7, 2011 - November 21, 2011 |
|
|
| Small-Molecule API Outsourcing |
| October 24, 2011 - November 7, 2011 |
|
|
| USP Monographs |
| October 10, 2011 - October 24, 2011 |
|
|
| Anticounterfeiting Solutions |
| September 26, 2011 - October 10, 2011 |
|
|
| FDA's Enforcement Strategy |
| September 12, 2011 - September 26, 2011 |
|
|
| Quality by Design and APIs |
| August 29, 2011 - September 12, 2011 |
|
|
| Outsourcing Biologics |
| August 15, 2011 - August 29, 2011 |
|
|
| FDA Biosimilars Pathway |
| August 1, 2011 - August 15, 2011 |
|
|
| High-potency APIs |
| July 18, 2011 - August 1, 2011 |
|
|
| Biosimilars |
| July 6, 2011 - July 18, 2011 |
|
|
| Emerging markets |
| July 4, 2011 - July 18, 2011 |
|
|
| Carbon footprints |
| June 21, 2011 - July 5, 2011 |
|
|
| Needleless devices |
| June 6, 2011 - June 20, 2011 |
|
|
| BioPharm Survey :: Involvement In the Biopharmaceutical Industry |
| February 20, 2007 - February 20, 2008 |
|
|
